Pfanstiehl Launches Parenteral-Grade Sodium Succinate
Pfanstiehl has announced the launch of the first cGMP Sodium Succinate Hexahydrate (NF) to the market, which is compliant with the new USP Monograph established in 2017. Pfanstiehl previously launched the first cGMP Sodium Succinate Anhydrous (NF) to the market in March 2018.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.